A preclinical randomized controlled multi-centre trial of anti-interleukin-17A treatment for acute ischaemic stroke
Mathias Gelderblom(Universität Hamburg), Tim Magnus(Universität Hamburg), Karoline Degenhardt(Universität Hamburg), Götz Thomalla(Universität Hamburg), Marius Piepke(Universität Hamburg), Carina Jørgensen(University of Southern Denmark), Jan Sedlacik, Jan‐Kolja Strecker(University of Münster), Josef Anrather(Cornell University), Bettina Hjelm Clausen(University of Southern Denmark), Christian Gerloff(Universität Hamburg), Lidia García‐Bonilla(Cornell University), Thiruma V. Arumugam(La Trobe University), Christian Bernreuther(Universität Hamburg), Jens Minnerup(Defense Information Systems Agency), Peter Ludewig(Universität Hamburg), Ines Sophie Schädlich(Universität Hamburg), Hans O. Pinnschmidt(Universität Hamburg), Cornelius Faber(University of Münster)
Cited by 12
Related Papers
Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
|The Lancet Neurology|2020|1.4k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k
Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis
|The Journal of Experimental Medicine|2000|984
Inflammation and Stroke: An Overview
|Neurotherapeutics|2016|951